Anti-BMP2 antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | BMP2 |
| Immunogen: | Synthetic peptide (KLH-coupled) within human BMP2 N terminal. |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:1000); Immunohistochemistry (1:100-1:200); Immunocytochemistry (1:100-1:200); Flow Cytometry (1:100-1:200) |
| Reactivity: | Mouse, Rat and Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 40% glycerol, 0.05% NaN3. |
| Concentration: | 1mg/ml |
| Purity: | Peptide affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | BDA2 antibody |
| BMP-2 antibody | |
| BMP-2A antibody | |
| Bmp2 antibody | |
| BMP2_HUMAN antibody | |
| BMP2A antibody | |
| Bone morphogenetic protein 2 antibody | |
| Bone morphogenetic protein 2A antibody |
Show More
Target information
Induces cartilage and bone formation (PubMed:3201241). Stimulates the differentiation of myoblasts into osteoblasts via the EIF2AK3-EIF2A- ATF4 pathway. BMP2 activation of EIF2AK3 stimulates phosphorylation of EIF2A which leads to increased expression of ATF4 which plays a central role in osteoblast differentiation. In addition stimulates TMEM119, which upregulates the expression of ATF4 (PubMed:24362451).
Provider
Erpantech Laboratory